Your browser doesn't support javascript.
loading
Biological Characterization of SB3, a Trastuzumab Biosimilar, and the Influence of Changes in Reference Product Characteristics on the Similarity Assessment.
Lee, Jae Hee; Paek, Kyungyeol; Moon, Jae Hyon; Ham, Sunyoung; Song, Jinsu; Kim, Seokkyun.
Afiliação
  • Lee JH; Quality Evaluation Team, Samsung Bioepis Co., Ltd, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea. jaehee81.lee@samsung.com.
  • Paek K; Quality Evaluation Team, Samsung Bioepis Co., Ltd, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea.
  • Moon JH; Quality Evaluation Team, Samsung Bioepis Co., Ltd, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea.
  • Ham S; Quality Evaluation Team, Samsung Bioepis Co., Ltd, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea.
  • Song J; Quality Evaluation Team, Samsung Bioepis Co., Ltd, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea.
  • Kim S; Quality Evaluation Team, Samsung Bioepis Co., Ltd, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea.
BioDrugs ; 33(4): 411-422, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31190280
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Medicamentos Biossimilares / Trastuzumab / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Medicamentos Biossimilares / Trastuzumab / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article